Dr. Michael Moeller, MD

NPI: 1598765877
Total Payments
$1,032
2024 Payments
$117.78
Companies
15
Transactions
38
Medicare Patients
269
Medicare Billing
$32,485

Payment Breakdown by Category

Food & Beverage$1,032 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,032 38 100.0%

Top Paying Companies

Company Total Records Latest Year
Sunovion Pharmaceuticals Inc. $418.78 12 $0 (2018)
Allergan Inc. $125.82 2 $0 (2017)
Neurocrine Biosciences, Inc. $107.72 1 $0 (2017)
Alkermes, Inc. $91.79 5 $0 (2024)
Otsuka America Pharmaceutical, Inc. $69.64 5 $0 (2022)
Lundbeck LLC $46.61 3 $0 (2024)
Vanda Pharmaceuticals Inc. $43.41 2 $0 (2024)
E.R. Squibb & Sons, L.L.C. $24.34 1 $0 (2024)
Tris Pharma Inc $18.98 1 $0 (2023)
Teva Pharmaceuticals USA, Inc. $15.89 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $117.78 6 Lundbeck LLC ($32.25)
2023 $50.05 3 Alkermes, Inc. ($31.07)
2022 $77.24 5 Otsuka America Pharmaceutical, Inc. ($38.45)
2021 $48.80 3 Alkermes, Inc. ($18.86)
2020 $27.66 2 Otsuka America Pharmaceutical, Inc. ($16.35)
2019 $14.36 1 Lundbeck LLC ($14.36)
2018 $338.30 9 Sunovion Pharmaceuticals Inc. ($306.99)
2017 $357.36 9 Allergan Inc. ($125.82)

All Payment Transactions

38 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/11/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $26.94 General
Category: SCHIZOPHRENIA
12/05/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $24.34 General
Category: Psychiatry/Psychology
11/07/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $14.72 General
Category: PSYCHIATRY
09/05/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $17.53 General
Category: PSYCHIATRY
07/25/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $18.36 General
Category: CNS
02/08/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $15.89 General
Category: Neurology
10/19/2023 Tris Pharma Inc Dyanavel XR (Drug) Food and Beverage In-kind items and services $18.98 General
Category: ADHD
03/23/2023 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $17.66 General
Category: CNS
02/09/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $13.41 General
Category: CNS
12/07/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $14.15 General
Category: PSYCHIATRY
10/13/2022 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA INITIO Food and Beverage In-kind items and services $23.50 General
Category: CNS
09/15/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $11.82 General
Category: PSYCHIATRY
05/24/2022 Janssen Pharmaceuticals, Inc INVEGA TRINZA (Drug), INVEGA SUSTENNA Food and Beverage In-kind items and services $15.29 General
Category: Neuroscience
05/05/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $12.48 General
Category: PSYCHIATRY
11/06/2021 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA INITIO Food and Beverage In-kind items and services $18.86 General
Category: CNS
04/08/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.71 General
Category: NEUROSCIENCE
03/25/2021 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $15.23 General
Category: PSYCHIATRY
11/06/2020 Takeda Pharmaceuticals U.S.A., Inc. VYVANSE (Drug) Food and Beverage In-kind items and services $11.31 General
Category: NEUROSCIENCE
08/27/2020 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug) Food and Beverage In-kind items and services $16.35 General
Category: PSYCHIATRY
01/10/2019 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $14.36 General
Category: PSYCHIATRY
11/07/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $123.73 General
Category: CNS
09/13/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $4.78 General
Category: CNS
08/23/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $10.97 General
Category: CNS
06/28/2018 Sunovion Pharmaceuticals Inc. LATUDA (Drug) Food and Beverage In-kind items and services $11.46 General
Category: CNS
05/24/2018 Vanda Pharmaceuticals Inc. Hetlioz (Drug), Fanapt Food and Beverage In-kind items and services $16.47 General
Category: Non-24-Hour Sleep-Wake Disorder

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 49 106 $13,584 $7,235
2022 2 58 111 $11,177 $6,626
2021 3 73 155 $15,255 $9,289
2020 3 89 175 $17,659 $9,335
Total Patients
269
Total Services
547
Medicare Billing
$32,485
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 29 66 $8,250 $5,229 63.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 20 40 $5,334 $2,006 37.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 34 72 $8,968 $5,483 61.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 24 39 $2,208 $1,144 51.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 37 75 $9,238 $6,030 65.3%
99309 Subsequent nursing facility visit, typically 25 minutes per day Facility 2021 15 33 $4,125 $2,069 50.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 21 47 $1,892 $1,189 62.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 38 83 $10,476 $5,449 52.0%
99309 Subsequent nursing facility visit, typically 25 minutes per day Facility 2020 26 40 $5,255 $2,739 52.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 25 52 $1,928 $1,147 59.5%

About Dr. Michael Moeller, MD

Dr. Michael Moeller, MD is a Psychiatry healthcare provider based in Mankato, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598765877.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Moeller, MD has received a total of $1,032 in payments from pharmaceutical and medical device companies, with $117.78 received in 2024. These payments were reported across 38 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,032).

As a Medicare-enrolled provider, Moeller has provided services to 269 Medicare beneficiaries, totaling 547 services with total Medicare billing of $32,485. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Mankato, MN
  • Active Since 07/28/2005
  • Last Updated 10/01/2012
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1598765877

Products in Payments

  • LATUDA (Drug) $418.78
  • VRAYLAR (Drug) $140.53
  • INGREZZA (Drug) $107.72
  • REXULTI (Drug) $99.90
  • ARISTADA (Drug) $55.77
  • LYBALVI (Drug) $36.02
  • FANAPT (Drug) $26.94
  • COBENFY (Drug) $24.34
  • Dyanavel XR (Drug) $18.98
  • Hetlioz (Drug) $16.47
  • ABILIFY MAINTENA (Drug) $16.35
  • UZEDY (Drug) $15.89
  • INVEGA TRINZA (Drug) $15.29
  • CAPLYTA (Drug) $15.23
  • NUPLAZID (Drug) $12.03
  • VYVANSE (Drug) $11.31

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Mankato